Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teh-Ia Huo

Showing results (131-140 of 229) with videos related to

Pageof 23
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|August 12, 2015
The Impact of Spironolactone on the Severity of Portal-Systemic Collaterals and Hepatic Encephalopathy in Cirrhotic RatsShao-Jung Hsu, Sun-Sang Wang, Teh-Ia Huo, et al.
Scandinavian Journal of Gastroenterology|July 13, 2022
Cryptogenic hepatocellular carcinoma: characteristics, outcome, and prognostic role of albumin-bilirubin (ALBI) grade vs easy ALBI gradeShu-Yein Ho, Mei-Hsia Yuan, Po-Hong Liu, et al.
Scientific Reports|March 5, 2020
Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinomaShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Journal of Gastrointestinal Oncology|May 20, 2021
ALBI grade in dialysis patients with hepatocellular carcinoma: prognostic impact and staging strategyShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Journal of Clinical Gastroenterology|June 14, 2011
Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic predictionI-Fang Hsin, Chia-Yang Hsu, Hui-Chun Huang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 24, 2009
Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinomaTeh-Ia Huo, Chia-Yang Hsu, Yi-Hsiang Huang, et al.
Journal of Clinical Gastroenterology|April 10, 2014
Radiofrequency ablation is better than surgical resection in patients with hepatocellular carcinoma within the Milan criteria and preserved liver function: a retrospective study using propensity score analysesYun-Hsuan Lee, Chia-Yang Hsu, Chen-Wei Chu, et al.
American Journal of Clinical Oncology|July 24, 2019
An Albumin-Bilirubin (ALBI) Grade-based Prognostic Model For Patients With Hepatocellular Carcinoma Within Milan CriteriaShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Journal of Gastroenterology and Hepatology|October 4, 2016
ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD EraPo-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, et al.
Cancer|June 22, 2010
Selecting an optimal staging system for hepatocellular carcinoma: comparison of 5 currently used prognostic modelsChia-Yang Hsu, Cheng-Yuan Hsia, Yi-Hsiang Huang, et al.
Pageof 23

Showing results (131-140 of 229) with videos related to

Sort By:
Pageof 23
The Journal of Pharmacology and Experimental Therapeutics|August 12, 2015
The Impact of Spironolactone on the Severity of Portal-Systemic Collaterals and Hepatic Encephalopathy in Cirrhotic RatsShao-Jung Hsu, Sun-Sang Wang, Teh-Ia Huo, et al.
Scandinavian Journal of Gastroenterology|July 13, 2022
Cryptogenic hepatocellular carcinoma: characteristics, outcome, and prognostic role of albumin-bilirubin (ALBI) grade vs easy ALBI gradeShu-Yein Ho, Mei-Hsia Yuan, Po-Hong Liu, et al.
Scientific Reports|March 5, 2020
Evolution of etiology, presentation, management and prognostic tool in hepatocellular carcinomaShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Journal of Gastrointestinal Oncology|May 20, 2021
ALBI grade in dialysis patients with hepatocellular carcinoma: prognostic impact and staging strategyShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Journal of Clinical Gastroenterology|June 14, 2011
Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic predictionI-Fang Hsin, Chia-Yang Hsu, Hui-Chun Huang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 24, 2009
Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinomaTeh-Ia Huo, Chia-Yang Hsu, Yi-Hsiang Huang, et al.
Journal of Clinical Gastroenterology|April 10, 2014
Radiofrequency ablation is better than surgical resection in patients with hepatocellular carcinoma within the Milan criteria and preserved liver function: a retrospective study using propensity score analysesYun-Hsuan Lee, Chia-Yang Hsu, Chen-Wei Chu, et al.
American Journal of Clinical Oncology|July 24, 2019
An Albumin-Bilirubin (ALBI) Grade-based Prognostic Model For Patients With Hepatocellular Carcinoma Within Milan CriteriaShu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, et al.
Journal of Gastroenterology and Hepatology|October 4, 2016
ALBI and PALBI grade predict survival for HCC across treatment modalities and BCLC stages in the MELD EraPo-Hong Liu, Chia-Yang Hsu, Cheng-Yuan Hsia, et al.
Cancer|June 22, 2010
Selecting an optimal staging system for hepatocellular carcinoma: comparison of 5 currently used prognostic modelsChia-Yang Hsu, Cheng-Yuan Hsia, Yi-Hsiang Huang, et al.
Pageof 23